Pharmacoeconomics short course
2 day short course at Bangor University
12th - 13th April 2018
Registration deadline: 26th March 2018
The Centre for Health Economics & Medicines Evaluation (CHEME) was founded in 2001, and is now one of the leading health economics centres in the UK.
Researchers at CHEME produce world leading research across a range of health economic and medicines evaluation activities. These include pharmaceutical economics and policy, health technology assessment, trial based economic evaluations and medicines use research. At the last Research Excellence Framework, research outputs were rated 3rd out of 94 institutions across the UK.
Core strengths of CHEME are our multidisciplinary approach to health research and close alliance with the NHS. At the end of this short course delegates will have gained an appreciation of the basic principles of pharmacoeconomics, be able to interpret the results of health technology assessments, gain insight into the perspectives of decision makers and critical appraisal skills for economic evaluations
Who is this course for?
Pharmacists, clinicians, allied health professional, postgraduate students and others with an interest in pharmacoeconomics and who wish to learn about the methods and application of health technology assessment. No prior knowledge of economics is required.
We will cover:
- Medicines and the NHS
- Introduction to Health Technology Assessment (HTA)
- Patient Outcomes
- Evidence synthesis
- Trial-based economic evaluation
- Resource use and costs
- Health economic modelling
- Critical appraisal
Course director: Professor Dyfrig Hughes, supported by visiting speakers.
Price: £750 (Includes meals and accomodation in the Management Centre, Bangor.)